Identifying Antigens in Peripheral T-Cell Lymphoma
Author Information
Author(s): Christopher D. O. Cooper, Charles H. Lawrie, Amanda P. Liggins, Graham P. Collins, Christian S. R. Hatton, Karen Pulford, Alison H. Banham
Primary Institution: Nuffield Department of Clinical Laboratory Sciences, University of Oxford
Hypothesis
The study aims to identify potential antigens associated with the pathogenesis of peripheral T-cell lymphoma (PTCL) using the SEREX technique.
Conclusion
The study identifies nine novel antigens that are immunologically recognized by patients with PTCL, NOS, suggesting their potential role in the disease's pathogenesis.
Supporting Evidence
- Nine antigens were identified that are recognized by the immune system of PTCL patients.
- CEP250 was specifically recognized by patients' sera and showed increased expression in T-cell malignancies.
- ZBTB44 was recognized by antibodies in 66% of PTCL, NOS patients.
Takeaway
Researchers found new proteins that the immune system of patients with a type of lymphoma can recognize, which might help in understanding and treating the disease.
Methodology
The SEREX technique was used to screen a testis cDNA library with sera from PTCL patients to identify associated antigens.
Limitations
The identified antigens may not be specific to lymphoma, as some were also recognized by healthy controls.
Participant Demographics
The study included sera from 9 patients with PTCL, NOS, and 17 normal controls.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website